Skip to main content

Advertisement

Log in

Artificial intelligence in longevity medicine

  • Comment
  • Published:

From Nature Aging

View current issue Submit your manuscript

Recent advances in deep learning enabled the development of AI systems that outperform humans in many tasks and have started to empower scientists and physicians with new tools. In this Comment, we discuss how recent applications of AI to aging research are leading to the emergence of the field of longevity medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: AI in longevity medicine.

References

  1. Cutler, R. G. & Mattson, M. P. Ageing Res. Rev. 5, 221–238 (2006).

    Article  CAS  Google Scholar 

  2. de Grey, A. D. N. J. SELT https://doi.org/10.2202/1941-6008.1011 (2007).

  3. Kaneshiro, B., Geling, O., Gellert, K. & Millar, L. Hawaii Med. J. 70, 168–171 (2011).

    PubMed  PubMed Central  Google Scholar 

  4. Yadav, D., Singh, R., Vatsa, M. & Noore, A. PLoS ONE 9, e112234 (2014).

    Article  Google Scholar 

  5. Esteva, A. et al. Nat. Med. 25, 24–29 (2019).

    Article  CAS  Google Scholar 

  6. Mnih, V. et al. Nature 518, 529–533 (2015).

    Article  CAS  Google Scholar 

  7. Hinkson, I. V., Madej, B. & Stahlberg, E. A. Front. Pharmacol. 11, 770 (2020).

    Article  Google Scholar 

  8. Zhavoronkov, A. & Mamoshina, P. Trends Pharmacol. Sci. 40, 546–549 (2019).

    Article  CAS  Google Scholar 

  9. Mamoshina, P. et al. Sci. Rep. 9, 142 (2019).

    Article  Google Scholar 

  10. Hou, Y.-C. C. et al. Proc. Natl Acad. Sci. USA 117, 3053–3062 (2020).

    Article  CAS  Google Scholar 

  11. Moore, J. H. & Raghavachari, N., Workshop Speakers. Front. Artif. Intell. 2, 12 (2019).

    Article  Google Scholar 

  12. Zhavoronkov, A., Li, R., Ma, C. & Mamoshina, P. Aging 11, 10771–10780 (2019).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

K.F.L. and A.Z. both contributed to the design and implementation of the research and to the writing of the manuscript. E.B. contributed to the rewriting and editing of the manuscript and supported the initial design.

Corresponding author

Correspondence to Alex Zhavoronkov.

Ethics declarations

Competing interests

K.F.L. is the founder of Sinovation Ventures, a commercial venture fund investing in AI with commercial interests in a broad range of AI companies and projects relating to longevity medicine. A.Z. is the founder and shareholder of Insilico Medicine, a drug discovery company with a focus on aging and age-related diseases, and Deep Longevity, a commercial company specializing in biomarker development and DACs. E.B. is an independent advisor to Insilico Medicine.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhavoronkov, A., Bischof, E. & Lee, KF. Artificial intelligence in longevity medicine. Nat Aging 1, 5–7 (2021). https://doi.org/10.1038/s43587-020-00020-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43587-020-00020-4

  • Springer Nature America, Inc.

This article is cited by

Navigation